HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Gion Selected Research

Plasminogen Activators (Plasminogen Activator)

10/2004The prognostic value of vascular endothelial growth factor, urokinase plasminogen activator and plasminogen activator inhibitor-1 in node-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Gion Research Topics

Disease

9Breast Neoplasms (Breast Cancer)
12/2013 - 02/2000
7Neoplasms (Cancer)
10/2008 - 02/2000
2Diarrhea
11/2011 - 12/2005
2Asthenia
11/2011 - 12/2005
1Cardiotoxicity
12/2013
1Pathologic Complete Response
12/2013
1Anorexia
11/2011
1Rectal Neoplasms (Rectal Cancer)
11/2011
1Neutropenia
11/2011
1Nausea
11/2011
1Colorectal Neoplasms (Colorectal Cancer)
10/2006
1Dyspnea (Shortness of Breath)
12/2005
1Thrombocytopenia (Thrombopenia)
12/2005
1Neuroendocrine Tumors (Neuroendocrine Tumor)
07/2005
1Urinary Bladder Neoplasms (Bladder Cancer)
04/2005
1Neoplasm Metastasis (Metastasis)
10/2004
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2003
1Squamous Cell Carcinoma of Head and Neck
05/2003
1Prostatic Neoplasms (Prostate Cancer)
04/2000

Drug/Important Bio-Agent (IBA)

4Biological ProductsIBA
12/2005 - 02/2000
3Hormones (Hormone)IBA
10/2008 - 01/2001
2ErbB Receptors (EGF Receptor)IBA
11/2011 - 12/2005
2DNA (Deoxyribonucleic Acid)IBA
10/2006 - 04/2005
2Tumor Biomarkers (Tumor Markers)IBA
06/2006 - 05/2001
2Biomarkers (Surrogate Marker)IBA
11/2004 - 05/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2004 - 01/2001
1Liposomes (Liposome)IBA
12/2013
1Trastuzumab (Herceptin)FDA Link
12/2013
1Docetaxel (Taxotere)FDA Link
12/2013
1Taxoids (Taxanes)IBA
12/2013
1AnthracyclinesIBA
12/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2013
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2013
1Monoclonal AntibodiesIBA
11/2011
1Panitumumab (Vectibix)FDA Link
11/2011
1Fluorouracil (Carac)FDA LinkGeneric
11/2011
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2011
1Estrogen ReceptorsIBA
10/2008
1Estrogens (Estrogen)FDA Link
10/2008
1Progesterone Receptors (Progesterone Receptor)IBA
10/2008
1TamoxifenFDA LinkGeneric
10/2008
1Codon (Codons)IBA
10/2006
1Epirubicin (Ellence)FDA LinkGeneric
12/2005
1AS 35IBA
12/2005
1Gefitinib (Iressa)FDA Link
12/2005
1Chromogranin AIBA
07/2005
1Plasminogen Activators (Plasminogen Activator)IBA
10/2004
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
10/2004
1Plasminogen Activator Inhibitor 1IBA
10/2004
1Glutathione (Reduced Glutathione)IBA
05/2003
1Glutathione Transferase (Glutathione S-Transferase)IBA
05/2003
1EnzymesIBA
10/2001
1Proteins (Proteins, Gene)FDA Link
10/2001
1Angiogenic ProteinsIBA
01/2001
1Cathepsin DIBA
01/2001
1Prostate-Specific Antigen (Semenogelase)IBA
04/2000
1Tissue Polypeptide AntigenIBA
02/2000
1Steroid Receptors (Steroid Receptor)IBA
02/2000
1K-18 conjugate (K18)IBA
02/2000
1Keratins (Keratin)IBA
02/2000

Therapy/Procedure

5Therapeutics
12/2013 - 02/2000
2Drug Therapy (Chemotherapy)
12/2013 - 05/2003
1Neoadjuvant Therapy
11/2011
1Radiotherapy
11/2011